International Flavors & Fragrances Inc. (BIT:1IFF)
Italy · Delayed Price · Currency is EUR 65.36
0.00 (0.00%)
At close: Jul 24, 2025, 5:30 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Nourish | 5.87B | Log In | Log In | Log In | Log In | Upgrade |
Nourish Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Health & Biosciences | 2.21B | Log In | Log In | Log In | Log In | Upgrade |
Health & Biosciences Growth | 5.91% | Log In | Log In | Log In | Log In | Upgrade |
Scent | 2.44B | Log In | Log In | Log In | Log In | Upgrade |
Scent Growth | -0.86% | Log In | Log In | Log In | Log In | Upgrade |
Pharma Solutions | 961.00M | Log In | Log In | Log In | Log In | Upgrade |
Pharma Solutions Growth | 6.16% | Log In | Log In | Log In | Log In | Upgrade |
Capex by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Nourish Capital Expenditures | 235.00M | Log In | Log In | Log In | Log In | Upgrade |
Nourish Capital Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Health & Biosciences Capital Expenditures | 73.00M | Log In | Log In | Log In | Log In | Upgrade |
Health & Biosciences Capital Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Scent Capital Expenditures | 70.00M | Log In | Log In | Log In | Log In | Upgrade |
Scent Capital Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Pharma Solutions Capital Expenditures | 85.00M | Log In | Log In | Log In | Log In | Upgrade |
Pharma Solutions Capital Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
EBITDA by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Nourish Adjusted Operating EBITDA | 824.00M | Log In | Log In | Log In | Log In | Upgrade |
Nourish Adjusted Operating EBITDA Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Health & Biosciences Adjusted Operating EBITDA | 654.00M | Log In | Log In | Log In | Log In | Upgrade |
Health & Biosciences Adjusted Operating EBITDA Growth | 6.39% | Log In | Log In | Log In | Log In | Upgrade |
Scent Adjusted Operating EBITDA | 518.00M | Log In | Log In | Log In | Log In | Upgrade |
Scent Adjusted Operating EBITDA Growth | -3.63% | Log In | Log In | Log In | Log In | Upgrade |
Pharma Solutions Adjusted Operating EBITDA | 209.00M | Log In | Log In | Log In | Log In | Upgrade |
Pharma Solutions Adjusted Operating EBITDA Growth | 16.04% | Log In | Log In | Log In | Log In | Upgrade |